Source: Annual Congress 2005 - Cellular and molecular mechanisms in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Foresi, C. Leone, E. Ansaldo, A. Corsico, R. D‘Ippolito, D. Olivieri, I. Cerveri (Sesto San Giovanni, Pavia, Parma, Italy). Eosinophils are increased in induced sputum from subjects with GOLD Stage 0. Eur Respir J 2005; 26: Suppl. 49, 690

Member's Comments

No comment yet.

Related content which might interest you: Sputum inflammatory cells in COPD patients classified according to GOLD 2011 guidelines Source: Eur Respir J 2016; 47: 978-980 Year: 2016 A case with positive sputum cytology of COPD GOLD II Source: Annual Congress 2010 - Thoracic Oncology Grand Round - an interactive session Year: 2010 GOLD stage 0 and risk of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 352s Year: 2003 Activated neutrophils are increased in bronchial biopsies from patients with severe COPD Source: Eur Respir J 2004; 24: Suppl. 48, 718s Year: 2004 MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 663s Year: 2006 Induced sputum in asthma and COPD: meassuring type and inflammation activity Source: Eur Respir J 2003; 22: Suppl. 45, 76s Year: 2003 Inflammatory markers and HDAC activity in induced sputum of smokers and COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 586s Year: 2007 Excess lung function decline is associated with GOLD stage 0 Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology Year: 2009 Exosomes are differentially present in bronchoalveolar lavage (BAL) of smokers and patients with COPD and IPF Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Blood eosinophil in smokers and mild and moderate COPD patients Source: International Congress 2017 – Latest insights into the management of chronic lung diseases Year: 2017 Stage 0 in GOLD does not predict future clinical COPD Source: Eur Respir J 2002; 20: Suppl. 38, 401s Year: 2002 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Elevated blood neutrophil levels in GOLD 2017 COPD group D – results from the TIE-study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 Ageing and disease duration may explain low sputum eosinophils in untreated moderate asthmatics Source: Eur Respir J 2003; 22: Suppl. 45, 480s Year: 2003 Inflammatory cell counts in induced sputum from non-allergic asthmatics and COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 317s Year: 2004 Expression of selected surface markers on macrophages in induced sputum from patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Eosinophils in peripheral blood are associated with eosinophils in sputum, BAL, and bronchial biopsies in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004 Bronchoalveolar lavage in COPD, smokers and non-smokers: inflammatory cells and macrophage phenotype Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD Year: 2004 Infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004